Renal Cell Carcinoma TNM Staging

TNM Staging | AJCC 2017


The TNM staging system anatomically classifies malignancies based on the extent of the primary tumour, regional lymph node involvement, and distant metastases. Staging helps physicians decide eligibility for clinical trials, define a patient's prognosis, and determine best treatment options.

The American Joint Committee on Cancer (AJCC) publishes the AJCC Cancer Staging Manual every 6-8 years. This tool is based on the 8th edition (2017) which represents the most up to date TNM staging guide.

Anatomic Stage/Prognostic Groups

Stage I T1 N0 M0
Stage II T2 N0 M0
Stage III T1 or T2
N0 or N1
Stage IV T4
Any T
Any N
Any N


American Joint Committee on Cancer (AJCC).

AJCC Cancer Staging Manual.

8th edition. New York: Springer; 2017.

The Renal Cell Carcinoma TNM Staging calculator is created by QxMD.

Created by on 25/04/2016

By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.

1. Primary Tumour (T)

0/3 completed